Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Conavi Med Corp (CNVIF)

Conavi Med Corp (CNVIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 24,023
  • Shares Outstanding, K 76,750
  • Annual Sales, $ 6,520 K
  • Annual Income, $ -14,670 K
  • EBIT $ -7 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.54
  • Price/Sales 3.54
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings $-0.09 on 12/29/25
  • Next Earnings Date 03/02/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +1,998,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2115 +47.99%
on 03/03/26
0.3330 -6.01%
on 02/09/26
-0.0056 (-1.76%)
since 02/06/26
3-Month
0.2115 +47.99%
on 03/03/26
0.4313 -27.43%
on 01/06/26
-0.0451 (-12.59%)
since 12/05/25
52-Week
0.2115 +47.99%
on 03/03/26
0.5550 -43.60%
on 10/16/25
-0.1116 (-26.28%)
since 03/06/25

Most Recent Stories

More News
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

- Successfully Closes $12M Public Offering,  Strengthens Balance Sheet and Supports Anticipated U.S. Launch - Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new peer-reviewed...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights

Next-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A Guidelines Reinforce Growing Adoption of Image-Guided PCI Peer-Reviewed Publications...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Expands Leadership Team to Support Next Phase of U.S. Commercialization

- Mark Quick Appointed Chief Financial Officer, Bringing Extensive Public Company Capital Markets Expertise - - Current CFO, Stefano Picone, will take on a Transitional Strategic Role to Support Leadership...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund

TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a commercial-stage medical device company focused on intravascular imaging solutions, today announced that...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical to Present at Planet MicroCap Showcase in Toronto

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

CNVIF : 0.3130 (+4.06%)
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025

TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing,...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System to US FDA for 510(k) Clearance

US FDA 510(k) Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company Preparing for US Commercial Launch following Clearance ...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)
Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights

US FDA 510(k) submission remains on track for calendar Q3 2025 Successful validation testing of Novasight Hybrid ™ system with key opinion leaders Recent academic publications underscore importance...

CNVI.VN : 0.420 (-2.33%)
CNVIF : 0.3130 (+4.06%)

Business Summary

Conavi Medical Corp. is focused on designing, manufacturing and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid(TM) System is the first system to combine both intravascular ultrasound and optical coherence tomography to enable...

See More

Key Turning Points

3rd Resistance Point 0.3753
2nd Resistance Point 0.3477
1st Resistance Point 0.3303
Last Price 0.3130
1st Support Level 0.2853
2nd Support Level 0.2577
3rd Support Level 0.2403

See More

52-Week High 0.5550
Fibonacci 61.8% 0.4238
Fibonacci 50% 0.3832
Fibonacci 38.2% 0.3427
Last Price 0.3130
52-Week Low 0.2115

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar